14:15 27/02/2015 Pfizer, Inc., Novartis AG Criticize CDC's Recommendation For Meningitis B ...
Pfizer, Inc., Novartis AG Criticize CDC's Recommendation For Meningitis B ...
Bidness ETC - 22 hours ago
Pfizer Inc. (NYSE:PFE) and Novartis AG (ADR) (NYSE:NVS) on Thursday received a green signal from the US Centers for Disease Control and Prevention (CDC) Advisory Committee on Immunization Practices (ACIP) for their meningitis B vaccines, for people ...
Pfizer, Novartis say meningitis vaccine scope too narrow - Reuters

13:24 27/02/2015 Pfizer Inc. v. Mylan Pharms. Inc.
Pfizer Inc. v. Mylan Pharms. Inc.
JD Supra (press release) - 23 hours ago
Case Name: Pfizer Inc. v. Mylan Pharms. Inc., Civ. No. 10-528-GMS, 2014 U.S. Dist. LEXIS 150283 (D. Del. Oct. 22, 2014) (Sleet, J.) (When a POSA would have to undertake significant guesswork to vary the parameters of prior-art compounds in order to ...

11:15 25/02/2015 NICE Okays Pfizer Inc. Inlyta, Rejects Dendreon Corporation Provenge; Bad ...
NICE Okays Pfizer Inc. Inlyta, Rejects Dendreon Corporation Provenge; Bad ...
Bidness ETC - Feb 25, 2015
The National Institute for Health and Care Excellence (NICE) issued two final guidelines today, recommending Pfizer Inc.'s (NYSE:PFE) Inlyta (axitinib) to be used as a second-line treatment option for kidney cancer, while rejecting Dendreon Corporation ...

23:48 24/02/2015 Pfizer to cut jobs at Cambridge research center
Pfizer to cut jobs at Cambridge research center
Boston Globe (subscription) - Feb 24, 2015
Drug giant Pfizer Inc. said Tuesday that it plans to pare an unspecified number of jobs at its Cambridge research center, opened last June, as part a broader cutback across its research operations.

15:00 18/02/2015 Has Pfizer Inc. Finally Solved Its Immuno-oncology Problem?
Has Pfizer Inc. Finally Solved Its Immuno-oncology Problem?
Motley Fool - Feb 18, 2015
Despite its humble beginnings and numerous setbacks, immunotherapy is on the cusp of becoming a standard part of cancer care, right alongside chemotherapy and surgery.

18:00 10/02/2015 Will Pfizer Inc. Break Up in 2015?
Will Pfizer Inc. Break Up in 2015?
Motley Fool - Feb 10, 2015
Pfizer has been churning out major new products such as its pneumonia and meningitis vaccine, Prevnar-13, during this time period.
Pfizer to pay $17 billion for Hospira Inc. - Allentown Morning Call
Pfizer Inc. Is Not Done With Acquisition Deals Yet - Bidness ETC

13:02 08/02/2015 Which Biotech Stock Should Pfizer, Inc. Buy?
Which Biotech Stock Should Pfizer, Inc. Buy?
Motley Fool - Feb 8, 2015
Earlier this week, Pfizer announced that it would acquire Hospira, the top provider of injectable drugs. The deal will net Pfizer an intriguing biosimilar program, but some suspect that the company is still hungry for more. If Pfizer is indeed still on ...

13:03 05/02/2015 5 Things Pfizer, Inc.'s Management Wants You to Know
5 Things Pfizer, Inc.'s Management Wants You to Know
Motley Fool - Feb 5, 2015
Times are challenging for Pfizer (NYSE: PFE ) , the largest pharmaceutical company in the world by revenue. In its latest quarterly report, Pfizer delivered a 3% decline in revenue to $13.12 billion as foreign currency translation headwinds and patent ...
Pfizer (PFE) Leading In Pre-Market Activity - TheStreet.com
Market Update (NYSE:PFE): Pfizer Marks World Cancer Day with Grant to Union ... - Jutia Group

12:17 05/02/2015 Pfizer to Buy Hospira for $16 Billion
Pfizer to Buy Hospira for $16 Billion
Wall Street Journal - Feb 5, 2015
Pfizer Inc. said Thursday it would buy smaller rival Hospira Inc. in a $16 billion deal that would transform the New York pharmaceutical company into a leading player in the emerging market for lower-priced knockoffs of costly biotech drugs.
Here's why Pfizer's deal for Hospira has a lot going for it - The Globe and Mail

11:03 08/03/2010 Form 4 PFIZER INC For: Feb 23 Filed by: DAMELIO FRANK A
Form 4 PFIZER INC For: Feb 23 Filed by: DAMELIO FRANK A
StreetInsider.com - Mar 8, 2010
Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b). 1. Name and Address of Reporting Person *. DAMELIO FRANK A. (Last), (First), (Middle). PFIZER INC.-CORP. SECRETARY. 235 EAST 42ND ...